如何建立一个勃发展的综合性瘤学计划
Irene Martyniuk1, Victoria Kennedy2, Judith Rose3
1Massachusetts General Hospital Cancer Center, Boston, Massachusetts, USA imartyniuk@mgb.org.
BMJ supportive & palliative care
|September 22, 2025
概括
综合性瘤学 (IO) 计划对于癌症护理至关重要. 本指南为领导者提供了建立和维持成功的IO计划的工具,以提高患者治疗和生存率.
科学领域:
- 在瘤学瘤学.
- 医疗保健管理的管理
背景情况:
- 综合性瘤学 (IO) 计划在癌症护理中越来越成为标准.
- 证据支持IO的疗效和患者益处.
- 系统的,基于证据的护理需要专门的知识和规划.
研究的目的:
- 为IO程序领导者和管理员提供程序开发和维护的工具.
- 为启动新的IO计划和振兴现有计划提供指导.
- 概述IO计划的建立和可持续性的管理和后勤必需品.
主要方法:
- 在集成瘤学会2024年国际年会上举办了会议前研讨会.
- 为IO项目领导者概述了关键建议和关键步骤.
- 描述了管理和后勤必需品,基于先前的临床专业知识.
主要成果:
- 研讨会为全球IO项目领导者和管理人员提供了必要的工具.
- 这篇文章概述了启动新IO计划的关键步骤.
- 为振兴现有IO计划和确保可持续性提供了指导.
结论:
- 有效的规划和管理对于成功的综合性瘤学计划至关重要.
- 提供的建议支持IO倡议的建立和可持续性.
- 该资源有助于提供系统的,以患者为中心的综合性瘤治疗.
相关概念视频
02:56Treatment Resistant Cancers
3.7K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.7K
02:49Cancer Therapies
9.8K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
9.8K
01:27Tumor Immunotherapy
1.8K
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
1.8K
02:57Targeted Cancer Therapies
8.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
8.6K
02:50Combination Therapies and Personalized Medicine
5.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.9K
02:53Adaptive Mechanisms in Cancer Cells
7.0K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
7.0K